SK Bioscience

2022.04.25

06:50

S. Korea's president-elect Yoon visits homegrown COVID-19 vaccine developer SK Bioscience

Asian Tech Press (Apr. 25) -- South Korea's president-elect Yoon Suk-yeol on Monday visited SK Bioscience Co., the developer of the country's first homegrown COVID-19 vaccine.

2022.03.16

03:30

SK Bioscience files for EUA for COVID-19 vaccine candidate in Britain

Asian Tech Press (Mar. 16) -- South Korean drugmaker SK Bioscience Co. has submitted an application to the UK drug regulator for an emergency use authorization (EUA) of its COVID-19 vaccine candidate.

2021.08.30

08:27

SK Bioscience begins Phase III clinical trial of COVID-19 vaccine candidate

SEOUL, Aug. 30 (Yonhap) -- South Korean drugmaker SK Bioscience Co. said Monday it has begun the phase three clinical trial of its COVID-19 vaccine candidate.

2021.07.19

04:43

SK tells Vietnamese President it is willing to provide vaccines to Vietnam as a priority

According to Yonhap News Agency, SK Group expressed in person to Vietnamese President Nguyen Xuan Phuc its intention to supply vaccines to Vietnam on a priority basis.

2021.06.21

04:27

S. Korea's SK Bioscience to invest $132 million to boost vaccine production

South Korea’s SK bioscience said on Monday it plans to expand vaccine production by investing about 150 billion won ($132 million) by 2024 to add production capacity, as well as equipping its plant to make newer mRNA and viral vector vaccines.

2021.05.17

11:30

SK Bioscience obtains GMP from the European Medicines Agency

South Korea's SK Bioscience said on Monday its COVID-19 vaccine facility had obtained European Union Good Manufacturing Practices (GMP) certification.

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Tesla's (TSLA.O) shares fell as much as 5% in pre-market trading after its fourth-quarter deliveries fell short of expectations.
                            2025-01-02

                                    Tesla (TSLA.O) produced 22,727 other models in the fourth quarter, compared with market forecasts of 22,790.
                            2025-01-02

                                    Yunding Technology: The company currently has no self-owned AI hardware products for sale
                            2025-01-02

                                    Tesla (TSLA.O) Model 3/Y production in the fourth quarter of 2024 was 436,718 units.
                            2025-01-02

                                    Tesla (TSLA.O) shares fell 2.7% in pre-market trading.
                            2025-01-02